An investigational targeted therapy designed to block one of the most common genetic drivers of pancreatic cancer has shown ...
The signs of pancreatic cancer are very subtle and often overlooked. Dr Sethi shares seven things to look out for to detect ...
An investigational targeted therapy designed to block one of the most common genetic drivers of pancreatic cancer has shown ...
Targeted compound daraxonrasib successfully blocks multiple KRAS variants to double survival limits in clinical trials.
Navigating a cancer diagnosis often begins with a simple online search. The new Cancer Search Bar series from CURE brings those commonly searched questions directly to oncology ex ...
Northwestern Medicine scientists have demonstrated that a highly sensitive blood test can detect traces of pancreatic cancer ...
Pancreatic cancer's neoadjuvant debate is no longer about whether systemic therapy matters. It is about when to give it. The field is split between clinicians who view preoperative treatment as the ...
A new experimental drug may offer hope for pancreatic cancer patients. One of deadliest types of cancer in the United States, an estimated 52,740 Americans will die from the disease this year, ...
Data from a major breakthrough in the fight against pancreatic cancer was released this month, highlighting a new pill that targets the root cause of how the disease exists and spreads. Arizona ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results